In a groundbreaking new study led by University of Minnesota biomedical engineers, artificial blood vessels bioengineered in the lab and implanted in young lambs are capable of growth within the recipient. If confirmed in humans, these new vessel grafts would prevent the need for repeated surgeries in some children with congenital heart defects.
The study was published in the journal Nature Communications.
One of the greatest challenges in vessel bioengineering is designing a vessel that will grow with its new owner.
In this study, University of Minnesota Department of Biomedical Engineering Professor Robert Tranquillo and his colleagues generated vessel-like tubes in the lab from a post-natal donor’s skin cells and then removed the cells to minimize the chance of rejection. This also means the vessels can be stored and implanted when they are needed, without the need for customized cell growth of the recipient. When implanted in a lamb, the tube was then repopulated by the recipient’s own cells allowing it to grow.
“This might be the first time we have an ‘off-the-shelf’ material that doctors can implant in a patient, and it can grow in the body,” Tranquillo said. “In the future, this could potentially mean one surgery instead of five or more surgeries that some children with heart defects have before adulthood.”
To develop the material for this study, researchers combined sheep skin cells in a gelatin-like material, called fibrin, in the form of a tube and then rhythmically pumped in nutrients necessary for cell growth using a bioreactor for up to five weeks. The pumping bioreactor provided both nutrients and “exercise” to strengthen and stiffen the tube. The bioreactor, developed with Zeeshan Syedain, a senior research associate in Tranquillo’s lab, was a key component of developing the bioartificial vessel to be stronger than a native artery so it wouldn’t burst in the patient.
The researchers then used special detergents to wash away all the sheep cells, leaving behind a cell-free matrix that does not cause immune reaction when implanted. When the vessel graft replaced a part of the pulmonary artery in three lambs at five weeks of age, the implanted vessels were soon populated by the lambs’ own cells, causing the vessel to bend its shape and grow together with the recipient until adulthood.
“What’s important is that when the graft was implanted in the sheep, the cells repopulated the blood vessel tube matrix,” Tranquillo said. “If the cells don’t repopulate the graft, the vessel can’t grow. This is the perfect marriage between tissue engineering and regenerative medicine where tissue is grown in the lab and then, after implanting the decellularized tissue, the natural processes of the recipient’s body makes it a living tissue again.”
At 50 weeks of age, the sheep’s blood vessel graft had increased 56 percent in diameter and the amount of blood that could be pumped through the vessel increased 216 percent. The collagen protein also had increased 465 percent, proving that the vessel had not merely stretched but had actually grown. No adverse effects such as clotting, vessel narrowing, or calcification were observed.
“We saw growth and none of the bad things happened,” Tranquillo said. “The results are very encouraging.”
Tranquillo said the next step is talking with doctors to determine the feasibility of requesting approval from the Food and Drug Administration (FDA) for human clinical trials within the next few years.
The Latest on: Artificial blood vessels
via Google News
The Latest on: Artificial blood vessels
- Intravascular Ultrasound (IVUS) Market To Reach USD 555.3 Million By 2027 | Reports and Dataon February 26, 2020 at 4:29 pm
New York, Feb. 26, 2020 -- The global intravascular ultrasound (IVUS) market is forecast to reach USD 555.3 Million by 2027, according to a new report by Reports and Data..
- Artificial Blood Vessels Industry Report, 2020-2025 - Stringent Regulatory Framework and High Costs are Hampering Growthon February 25, 2020 at 8:51 am
DUBLIN, Feb. 25, 2020 /PRNewswire/ -- The "Artificial Blood Vessels Market - Growth, Trends, and Forecast (2020 - 2025)" report has been added to ResearchAndMarkets.com's offering. Research institutes ...
- Global Artificial Blood Vessels Market, Forecast to 2025 - Aortic Disease Applications Will Hold a Large Share of the Marketon February 25, 2020 at 3:33 am
Dublin, Feb. 25, 2020 (GLOBE NEWSWIRE) -- The "Artificial Blood Vessels Market - Growth, Trends, and Forecast (2020 - 2025)" report has been added to ResearchAndMarkets.com's offering. Research ...
- Nick Lees: Artificial heart another chance at beating the odds for Edmonton chef Brad Smoliakon February 23, 2020 at 3:55 pm
“I no longer have a pulse — the blood has a constant flow.” Smoliak was born with his heart literally backwards, a congenital defect called transposition of the great vessels (TGV).
- Want to Look Inside a Brain? With Transparent Organs, You Canon February 21, 2020 at 4:00 am
They can image networks of teeny-tiny blood vessels, undisturbed in their natural arrangement ... so as to replicate that intricacy in artificial organs. After all, if you copy the structure, you ...
- How a discovery in 'junk' DNA could protect against heart diseaseon February 19, 2020 at 11:00 am
Atherosclerosis happens when the inner walls of blood vessels develop plaques made of fatty materials that clog up the arteries ... Another research team led by Queen Mary University of London ...
- The New Explosive Theory About What Doomed the Crew of the ‘Hunley’on February 19, 2020 at 6:04 am
The blood vessels on the surface of the brain dilate in an attempt to transport the acidity ... My boyfriend, Nick, helped find a test site: an isolated, expansive tobacco, cotton and sweet potato ...
- Roll with it: time to hit the face gymon February 17, 2020 at 10:05 pm
Often referred to as a kind of three-dimensional matrix, fascia is the sheet of fibrous connective tissue that runs throughout the entire body, linking muscles, bones, nerves and blood vessels. Rather ...
- What Is Causing These Disturbing Changes in a Young Woman's Eye?on February 17, 2020 at 11:24 am
The tumor appears to be freely mobile over the sclera and is surrounded by markedly dilated blood vessels. The patient's records show that for the previous ... and 3,500 IU neomycin sulphate (Maxitrol ...
via Bing News